CoChat

Complexity of MRI White Matter Hyperintensity Assessments in Relation to Cognition in Aging and Dementia from the Sunnybrook Dementia Study

Gao, Fu-qiang, Swartz, Richard H., Scheltens, Philip, Leibovitch, Farrell S., Kiss, Alex, Honjo, Kie, Black, Sandra E. · 2011 · Journal of Alzheimer's Disease

The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.

Abstract

PURPOSE: Quantification methods for white matter hyperintensities (WMH) on Magnetic Resonance Imaging are heterogeneous, deterring their application. This study compared three WMH rating scales, varying in complexity, and a volumetric method, to evaluate trade-offs between complexity and clinical utility in differentiating dementia subgroups and in correlating with cognition. METHODS: WMH were rated using the Fazekas, Age-Related White Matter Changes (ARWMC) and Scheltens scales, and segmented by computational volumetry in 108 patients with Alzheimer's Disease (AD), 23 with Mild Cognitive Impairment (MCI) and 34 normal controls (NC). Global and hippocampal atrophy, age and education, were accounted for in correlations of WMH with cognitive domains. RESULTS: Intra- and inter-rater reliability were high (intraclass correlation coefficients = 0.88-0.97) across rating scales. WMH scores of all scales were highly correlated with volumes (Spearman r = 0.78-0.90, Ps < 0.001), as well as with each other (Spearman r = 0.86-0.91, Ps < 0.001). The Fazekas scale showed significant separation between AD, MCI and NC using non-parametric analysis, while the ARWMC and Scheltens' scales, and WMH volumes demonstrated significant correlations (standardized β = -0.19 to -0.24, Ps < 0.05) with cognitive domain scores using multivariate regression analysis, controlling for age, education, global and hippocampal atrophy in patients with AD. CONCLUSIONS: This study suggests that the degree of complexity of WMH rating scales did not affect validation against WMH volumes, but did vary in validation against cognition. The simplest scale performed best in separating cognitive subgroups, but the more complex scales and quantification correlated better with cognitive measures, especially executive function. Hence the best choice of scale depends on the particular application.

Overview

Integrity signals

Registry

Crossref · 10.3233/jad-2011-0058

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 50

Metadata

Authors
Gao, F.-Q., Swartz, R. H., Scheltens, P., Leibovitch, F. S., Kiss, A., Honjo, K., & Black, S. E.
Affiliations
  • LC Campbell Cognitive Neurology Research Unit, Heart and Stroke Foundation Centre for Stroke Recovery, University of Toronto, Toronto, ON, Canada
  • University of Toronto (CA)
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Venue
Journal of Alzheimer's Disease
Published
2011-10-04
Volume
26
Issue
s3
Pages
379-388
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W1534377073
Cited by
50
References
36
Citations by year
2026: 2 · 2025: 1 · 2024: 3 · 2023: 1 · 2022: 4 · 2021: 1 · 2020: 3 · 2019: 5 · 2018: 2 · 2017: 6 · 2016: 4 · 2015: 4 · 2014: 7 · 2013: 4 · 2012: 2
FWCI
3.06
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Alzheimer s Disease (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
Canadian Institutes of Health Research (13129, MT13129)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
white matter hyperintensities
MeSH terms
Aged, Aged, 80 and over, Aging, Alzheimer Disease, Analysis of Variance, Brain, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Nerve Fibers, Myelinated, Statistics, Nonparametric, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.